von Willebrand factor, Jedi knight of the bloodstream

被引:333
|
作者
Springer, Timothy A. [1 ,2 ,3 ]
机构
[1] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA
[2] Boston Childrens Hosp, Div Hematol, Dept Med, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Biol Chem & Pharmacol, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
PLATELET GLYCOPROTEIN IB; FACTOR A1 DOMAIN; WEIBEL-PALADE BODIES; FACTOR A2 DOMAIN; THROMBOTIC THROMBOCYTOPENIC PURPURA; HUMAN VONWILLEBRAND-FACTOR; IX-V COMPLEX; LEUCINE-RICH REPEATS; DEEP-VEIN THROMBOSIS; FACTOR A3 DOMAIN;
D O I
10.1182/blood-2014-05-378638
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
When blood vessels are cut, the forces in the bloodstream increase and change character. The dark side of these forces causes hemorrhage and death. However, von Willebrand factor (VWF), with help from our circulatory system and platelets, harnesses the same forces to form a hemostatic plug. Force and VWF function are so closely intertwined that, like members of the Jedi Order in the movie Star Wars who learn to use "the Force" to do good, VWF may be considered the Jedi knight of the bloodstream. The long length of VWF enables responsiveness to flow. The shape of VWF is predicted to alter from irregularly coiled to extended threadlike in the transition from shear to elongational flow at sites of hemostasis and thrombosis. Elongational force propagated through the length of VWF in its thread-like shape exposes its monomers for multi-meric binding to platelets and subendothelium and likely also increases affinity of the A1 domain for platelets. Specialized domains concatenate and compact VWF during biosynthesis. A2 domain unfolding by hydrodynamic force enables postsecretion regulation of VWF length. Mutations in VWF in von Willebrand disease contribute to and are illuminated by VWF biology. I attempt to integrate classic studies on the physiology of hemostatic plug formation into modern molecular understanding, and point out what remains to be learned.
引用
收藏
页码:1412 / 1425
页数:14
相关论文
共 50 条
  • [31] Platelets and von Willebrand factor
    Schmugge, M
    Rand, ML
    Freedman, J
    TRANSFUSION AND APHERESIS SCIENCE, 2003, 28 (03) : 269 - 277
  • [32] Von Willebrand factor processing
    Brehm, Maria A.
    HAMOSTASEOLOGIE, 2017, 37 (01): : 59 - 72
  • [33] Clearance of von Willebrand factor
    Denis, Cecile V.
    Christophe, Olivier D.
    Oortwijn, Beatrijs D.
    Lenting, Peter J.
    THROMBOSIS AND HAEMOSTASIS, 2008, 99 (02) : 271 - 278
  • [34] von Willebrand factor and fibrinogen
    Ruggeri, Zaverio M.
    CURRENT OPINION IN CELL BIOLOGY, 1993, 5 (05) : 898 - 906
  • [35] von Willebrand factor and thrombosis
    Franchini, Massimo
    Lippi, Giuseppe
    ANNALS OF HEMATOLOGY, 2006, 85 (07) : 415 - 423
  • [36] Clearance of von Willebrand factor
    Casari, C.
    Lenting, P. J.
    Wohner, N.
    Christophe, O. D.
    Denis, C. V.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 202 - 211
  • [37] Recombinant von Willebrand factor
    Schwarz, HP
    Turecek, PL
    Pichler, L
    Mitterer, A
    Mundt, W
    Dorner, F
    Roussi, J
    Drouet, L
    THROMBOSIS AND HAEMOSTASIS, 1997, 78 (01) : 571 - 576
  • [38] Von Willebrand factor revisited
    Yasar, Senan J.
    Abdullah, Obai
    Fay, William
    Balla, Sudarshan
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2018, 31 (03) : 360 - 367
  • [39] Of von Willebrand factor and platelets
    Marijke Bryckaert
    Jean-Philippe Rosa
    Cécile V. Denis
    Peter J. Lenting
    Cellular and Molecular Life Sciences, 2015, 72 : 307 - 326
  • [40] Of von Willebrand factor and platelets
    Bryckaert, Marijke
    Rosa, Jean-Philippe
    Denis, Cecile V.
    Lenting, Peter J.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2015, 72 (02) : 307 - 326